Documents & Downloads

TD-6450

HCV Inhibitor

TD-6450 is an orally active inhibitor targeting the Hepatitis C Virus (HCV), specifically the pan-genotypic nonstructural protein 5A (NS5A). This compound demonstrates significant antiviral activity against HCV genotype 1A, making it a valuable reagent for research into hepatitis and related diseases. Its mechanism of action provides insights into antiviral strategies and therapeutic developments for HCV infections.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Inhibitor
CAS Number	1374883-22-3
Applications	HCV Inhibitor
Formula	C₄₁H₄₈F₃N₉O₆
Molecular Weight	819.87
SMILES	COC(N[C@@H](C(C)C)C(N1[C@H](C(N2)=NC=C2C(C=C3)=CC=C3C4=C(OC(F)(F)F)C=C(NC(C5=CN=C(C=C5)N6C[C@@H](N(C[C@H]6C)C(NC)=O)C)=O)C=C4)CCC1)=O)=O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.